Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies

Rosa Nadal, Hua Ling Tsai, Victoria J. Sinibaldi, Channing J. Paller, Emmanuel S. Antonarakis, Sammuel R. Denmeade, Michael A. Carducci, Mario A. Eisenberger

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences